Skip to main content
. 2015 Dec 14;37(3):968–977. doi: 10.1002/hbm.23080

Table 2.

Neuropsychological test scores obtained by Parkinson's disease patients and control subjects

Controls (n = 19) VH‐n (n = 12) VH‐p (n = 9) P value P value P value
Controls vs. VH‐n Controls vs. VH‐p VH‐n vs. VH‐p
MMSE 29.1 (1.2) 25.9 (2.7) 27 (1.7) <0.0005 0.03 0.53
IDDD 36.6 (4) 36.3 (4.1) 0.52
Attention domain
Digitsa 11.8 (2.2) 10.5 (2.6) 11.5 (2.1) 0.8 1 0.23
TMTAa 64.7 (27.1) 91.5 (39.5) 82.8 (39.6) 0.15 0.66 1
SW 49.8 (6.7) 33.8 (7.6) 39.9 (9) <0.00001 0.01 0.38
SC 43 (6.9) 31.4 (5.6) 35.4 (10) 0.001 0.06 1
Executive function domain
Phonemic fluency (60 seconds)a 15 (5.3) 7.8 (4.8) 10.4 (4.1) 0.001 0.09 1
SWC 46 (6.8) 36.8 (9.3) 38.9(8) 0.014 0.12 1
RPM 27.4 (4.4) 19 (3.8) 22.5 (6.1) <0.0005 0.06 0.51
TMTBa 139.2 (63.5) 240 (65) 234 (74.9) 0.001 0.004 1
Memory domain
Cerad Word delayed recalla 5.7 (1.4) 1.9 (2.1) 2.1 (1.3) <0.000005 <0.00005 1
Cerad Word Recognition 9 (1.5) 8.2 (1.4) 7.1 (1.8) 0.56 <0.01 1
FCSRT total recalla 46.9 (1.3) 46.2 (3.6) 45.6 (2.1) 1 0.41 1
Recall of figurea 6.5 (3.1) 2.7 (3.2) 4.5 (2.3) 0.006 0.36 0.43
Language domain
Bostona 51 (5.4) 39.4 (7.2) 47.1 (5.9) <0.0001 0.39 0.026
Semantic fluency (60 seconds)a 18.6 (4.6) 10.9 (3.1) 12.9 (5.6) <0.0005 0.01 0.82
Visuospatial function domain
Copy of figurea, b 9.89 (0.5) 9.7 (4) 9.6 (0.9) 1 1 1
Copy of intersecting pentagonsa, c 2: 19 (100%) 2:7 (58.3%) 2:5(55.6%) 0.04 0.02 0.42
1:4(33.3%) 1:1(11.1%)
0:1 (8.3%) 0:2(22.2%)

Data are presented as mean (standard deviation) or number (frequency).

VH‐n (VH‐negative): Parkinson's disease patients with mild cognitive impairment without visual hallucinations; VH‐p (VH‐positive): Parkinson's disease patients with mild cognitive impairment with visual hallucinations.

MMSE: Mini‐Mental State Examination; IDDD: Interview for daily living activities; TMT‐A: Trail Making Test A; SW: Stroop Words; SC: Stroop Colors; SWC: Stroop Words‐Colors; RPM: Raven Progressive Matrices; TMT‐B: Trail Making Test B; FCSRT: Free and Cue Selective Reminding test; Boston: Boston Naming Test; ns: non‐significant.

a

Test used for the diagnosis of MCI following MDS level II guidelines.

b

Copy and delayed recall of the most complex figure from the two simple figures of Massachusetts General Hospital (Sala et al., 2008).

c

Copy of intersecting pentagon is represented by frequency of presentation of each score because of its short range. Scoring was performed using a 0–2 rating scale in which 2 points indicated that all 10 angles were present and the 2 pentagons were intersecting, 1 point indicated that the two intersecting figures were present and one of them had 5 angles, and 0 indicating a poorer performance than the first two cases (Ala et al., 2001).